Heart & Vascular Center, Medical University of South Carolina, Ashley River Tower, 25 Courtenay Dr, MSC 226, Charleston, SC 29401, USA.
Radiology. 2012 Sep;264(3):679-90. doi: 10.1148/radiol.12112350. Epub 2012 Jul 19.
To systematically evaluate the incremental predictive value of cardiac computed tomographic (CT) angiography beyond the assessment of coronary artery calcium (CAC) in patients who present with acute chest pain but without evidence of acute coronary syndrome (ACS).
The human research committee approved this study and waived the need for individual written informed consent. The study was HIPAA compliant. A total of 458 patients (36% male; mean age, 55 years ± 11) with acute chest pain at low to intermediate risk for coronary artery disease underwent coronary calcification assessment with cardiac CT angiography. All patients who did not experience ACS at index hospitalization were followed for instances of a major adverse cardiac event (MACE), such as a myocardial infarct, revascularization, cardiac death, or angina requiring hospitalization. CAC score and cardiac CT angiography were used to derive the presence and extent of atherosclerotic plaque (calcified, noncalcified, or mixed), and obstructive lesions (>50% luminal narrowing) were related to outcomes by using univariate and adjusted Cox proportional hazards models.
Of the 458 patients, 70 (15%) experienced MACE (median follow-up, 13 months). Patients with no plaque at cardiac CT angiography remained free of events during the follow-up period, while 11 (5%) of 215 patients with no CAC had MACE. The extent of plaque was the strongest predictor of MACE independent of traditional risk factors (hazard ratio [HR], 151.77 for four or more segments containing plaque as compared with those containing no plaque; P < .001). Patients with mixed plaque were more likely to experience MACE (HR, 86.96; P = .002) than those with exclusively noncalcified plaque (HR, 58.06; P = .005) or exclusively calcified plaque (HR, 32.94; P = .02).
The strong prognostic value of cardiac CT angiography is incremental to its known diagnostic value in patients with acute chest pain without ACS and is independent of traditional risk factors and CAC.
系统评估在急性胸痛但无急性冠状动脉综合征(ACS)证据的患者中,心脏 CT 血管造影(CTA)在评估冠状动脉钙(CAC)之外的增量预测价值。
人体研究委员会批准了这项研究,并豁免了个人书面知情同意的需要。本研究符合 HIPAA 规定。共 458 名(36%为男性;平均年龄 55 岁±11 岁)具有低至中度冠状动脉疾病风险的急性胸痛患者接受了心脏 CT 血管造影的 CAC 评估。所有在索引住院期间未发生 ACS 的患者均随访主要不良心脏事件(MACE),如心肌梗死、血运重建、心脏死亡或需要住院治疗的心绞痛。CAC 评分和心脏 CT 血管造影用于确定动脉粥样硬化斑块(钙化、非钙化或混合)的存在和程度,并用单变量和调整后的 Cox 比例风险模型将阻塞性病变(>50%管腔狭窄)与结局相关联。
在 458 名患者中,有 70 名(15%)发生 MACE(中位随访时间为 13 个月)。在心脏 CT 血管造影中无斑块的患者在随访期间仍未发生事件,而 215 名无 CAC 的患者中有 11 名(5%)发生 MACE。斑块的程度是独立于传统危险因素的 MACE 的最强预测因子(危险比[HR],与无斑块的患者相比,有四个或更多节段包含斑块的患者为 151.77;P<0.001)。混合斑块患者发生 MACE 的可能性高于单纯非钙化斑块患者(HR,86.96;P=0.002)和单纯钙化斑块患者(HR,58.06;P=0.005)。
在无 ACS 的急性胸痛患者中,心脏 CT 血管造影具有强大的预后价值,且独立于传统危险因素和 CAC,其预测价值超过了其已知的诊断价值。